The relevance of fibrin formation and its stabilization in tumour growth and metastasis formation seems to be important but it still remains unclear.The role of F.XIII in this process may emerge from a variety of mechanisms it is involved in,including crosslink of fibrin molecules,α2AP incorporation into fibrin and reciprocal crosslink of fibronectin,fibrin and collagen. We studied F.XIII and its natural targets such as fibrinogen , fibronectin and α2AP in 61 patients with various inoperable neoplasms (21 with Ca mammae,18 with Ca ventriculi and 22 with Melanoma malignum).F.XIII activity was measured by dansylcadaverine incorporation method acc.to Lorand et α2F.XIII subunit “a” and “b”, f ibronect in , α2AP , AT III, α22M , α2AT and C-I plasma concentrations were estimated by means of rocket immunoelectrophoresis acc.to Laurell using monospecific antisera (Behringwerke AG,Marburg).The following tests were performed in all cases:fibrinogen concentration, euglobulin lysis time and serum FDP.In comparison with healthy subjects the patients revealed statistically significant decrease in F.XIII activity and its subunit “a“ and “b“ concentrations concomitant with lowered fibronectin and α2AP levels.No statistically significant correlations were found between F.XIII and its natural plasmatic substrates.Furthermore,the malignant patients showed decreased AT III concentrations,whereas α2CiI and α2AT levels were elevated.Prolongation of ELT concomitant with an increase of FDP concentration were also found. Differences in F.XIII level and in other haemostasis parameters were stated between different tumour types. Our data indicate that the role of F.XIII in malignancy is not limited to fibrin stabilization but its interactions with fibronectin and α2AP should be taken into account.